4 May 2022 –Reference is made to the announcement by Nordhealth AS (the "Company") on 6 April 2022 regarding the resolution to increase the Company's share capital in connection with the acquisition of Vetera and the 19.26% stake in Pet Leo.
The share capital increase pertaining to the issuance of the 191,747 new Class A shares has now been registered with the Norwegian Register of Business Enterprises. The Company's new registered share capital is NOK 80,191,746, divided into 45,191,747 Class A shares, carrying one vote each, and 34,999,999 Class B shares, carrying ten votes each. In total, the Company has 80,191,746 shares in issue, with a total of 395,191,737 votes. All shares have a nominal value of NOK 1.00.
DISCLOSURE REGULATION
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
For further information, please contact:
Charles Macbain, CEO
charles.macbain@nordhealth.com
+44 75 39 03 2200
Mari Orttenvuori, CFO
mari.orttenvuori@nordhealth.com
+358 46 8765 233
About Nordhealth
Nordhealth is a cloud-based healthcare SaaS company whose mission is to redefine digital healthcare. The Company’s products empower healthcare professionals to improve patient care, increase efficiency and expand their business. Since 2005, the Company has acquired and built cloud-based software for veterinary and therapeutic professionals and their patients, and now serves more than 30,000 professionals across 7,000 clinics and hospitals located in over 25 countries.
Headquartered in Espoo, Finland, Nordhealth has a solid footprint in the Nordic region and a growing presence internationally, with more than 300 employees working either remotely or from offices (collaboration hubs), serving a global customer base. Visit the company’s website at nordhealth.com.